Singapore clinched three of the top five private equity and venture capital deals struck in the region in the first quarter amid markedly slower economic activity across South-east Asia due to the pandemic.
We are pleased to inform you about the webinar “China, US and the World: geo-economic trends” organized by RsA Asia that will be held onsite at SJTU campus and online via zoom webinar, on July 11 2020.
"Singapore-based biotech firm Tychan Pte Ltd has started human clinical trials for a potential COVID-19 treatment known as TY027. From concept to clinical trials, the process took less than four months.
Directly developed as a COVID-19 treatment, TY027 is also being explored for its potential to prevent infection — a crucial application for the safe re-opening of economies and businesses."